Underdosing of synthetic cannabinoids, initial encounter

This code signifies a patient experiencing adverse effects or a lack of therapeutic effect due to receiving an insufficient amount of synthetic cannabinoids. This could involve a prescribed medication or a substance used for recreational purposes, where the administered dose was less than intended or required. The "initial encounter" designation indicates that the patient is receiving active treatment for the underdosing.

Apply this code when a patient presents with symptoms related to an inadequate dose of a synthetic cannabinoid, such as continued pain relief failure from a prescribed synthetic cannabinoid, or withdrawal-like symptoms in a patient accustomed to a higher dose. This code is appropriate for the first time a patient is seen for this specific underdosing event.

• Always sequence this code after the primary diagnosis for the condition being treated or the reason for the encounter.
• Consider adding an additional code for any specific symptoms or adverse effects experienced due to the underdosing.
• Ensure documentation clearly specifies "underdosing" and identifies the substance as a "synthetic cannabinoid."